PTC Therapeutics
PTCT
#2793
Rank
โ‚ฌ5.10 B
Marketcap
63,63ย โ‚ฌ
Share price
-1.18%
Change (1 day)
30.38%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: โ‚ฌ5.10 Billion

As of February 2026 PTC Therapeutics has a market cap of โ‚ฌ5.10 Billion. This makes PTC Therapeutics the world's 2793th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ5.10 B-4.86%
2025โ‚ฌ5.36 B60.17%
2024โ‚ฌ3.35 B78.18%
2023โ‚ฌ1.88 B-27.55%
2022โ‚ฌ2.59 B4.44%
2021โ‚ฌ2.48 B-26.56%
2020โ‚ฌ3.38 B27.5%
2019โ‚ฌ2.65 B74.91%
2018โ‚ฌ1.51 B163.22%
2017โ‚ฌ0.57 B62.04%
2016โ‚ฌ0.35 B-64.58%
2015โ‚ฌ1.00 B-28.23%
2014โ‚ฌ1.40 B378.77%
2013โ‚ฌ0.29 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of PTC Therapeutics was reported to be:

โ‚ฌ5.10 Billion
by Nasdaq info icon info icon
โ‚ฌ5.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚ฌ240.32 B 4,604.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚ฌ101.49 B 1,886.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.72 B-85.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ1.79 B-64.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚ฌ0.11 B-97.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚ฌ9.21 B 80.31%๐Ÿ‡บ๐Ÿ‡ธ USA